Yahoo
OTC Markets OTCPK - Delayed Quote USD

CannaPharmaRX, Inc. (CPMD)

0.0020 -0.0001 (-4.76%)
As of October 30 at 5:00:00 PM EDT. Market Open.
Chart Range Bar
Loading chart for CPMD
  • Previous Close 0.0021
  • Open 0.0020
  • Bid 0.0016 x 2000000
  • Ask 0.0021 x 27231000
  • Day's Range 0.0020 - 0.0020
  • 52 Week Range 0.0003 - 0.0100
  • Volume 30,000
  • Avg. Volume 65,940
  • Market Cap (intraday) 1.417M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.

www.cannapharmarx.com

26

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CPMD
61.54%
S&P 500 (^GSPC)
11.25%

1-Year Return

CPMD
60.00%
S&P 500 (^GSPC)
11.34%

3-Year Return

CPMD
58.93%
S&P 500 (^GSPC)
76.38%

5-Year Return

CPMD
89.47%
S&P 500 (^GSPC)
64.47%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY25
Revenue 231.61k
Earnings -1.41M
Profit Margin -610.28%

Q2

FY00

Q3

FY00

Q2

FY25

0
100M
200M
300M
400M
500M
-600.0%
-400.0%
-200.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.72%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.7M

  • Net Income Avi to Common (ttm)

    -11.32M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    555

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.7M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: